Physician profile
Eric D Norton
NPI 1932152139
$458.03
in general payments reported to CMS, 2019-2025
10 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $146 · 2024: $148 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $119.86 | 2023-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $89.41 | 2023-2025 | Freestyle Libre 3, Octrode |
| Amgen INC. | $66.54 | 2023-2025 | Repatha, Otezla, Krystexxa |
| Medtronic, INC. | $43.93 | 2024 | Corevalve Evolut R |
| Pfizer INC. | $43.82 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $25.30 | 2024 | Rexulti |
| Inari Medical, INC. | $19.30 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Inspire Medical Systems, INC. | $17.59 | 2025 | Inspire |
| Insightec,INC | $17.35 | 2025 | Exablate |
| Abbvie INC. | $14.93 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Norton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.